Kyverna Therapeutics(KYTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KYTX Kyverna Therapeutics

Pre-Mkt 12-23 08:20:58 EST

8.13

+0.94

+13.07%

盘前8.16

+0.03+0.37%

08:19 EST

High8.39	Low7.19	Vol3.37M
Open7.28	D1 Closing7.19	Amplitude16.71%
Mkt Cap464.46M	Tradable Cap270.70M	Total Shares57.13M
T/O26.68M	T/O Rate10.12%	Tradable Shares33.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":8.13,"timestamp":1766437200000,"preClose":7.19,"halted":0,"volume":3369571,"hourTrading":{"tag":"盘前","latestPrice":8.16,"preClose":8.13,"latestTime":"08:19 EST","volume":3780,"amount":31206.35889,"timestamp":1766495999421},"delay":0,"floatShares":33297000,"shares":57129503,"eps":-3.72055,"marketStatus":"Pre-Mkt","change":0.94,"latestTime":"12-23 08:20:58 EST","open":7.28,"high":8.3866,"low":7.185,"amount":26675152.8866214,"amplitude":0.167121,"askPrice":8.95,"askSize":100,"bidPrice":8.13,"bidSize":199,"shortable":3,"etf":0,"ttmEps":-3.72055,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"listingDate":1707368400000,"exchange":"NASDAQ","adjPreClose":8.13,"preHourTrading":{"tag":"盘前","latestPrice":8.16,"preClose":8.13,"latestTime":"08:19 EST","volume":3780,"amount":31206.35889,"timestamp":1766495999421},"postHourTrading":{"tag":"盘后","latestPrice":8.0999,"preClose":8.13,"latestTime":"19:59 EST","volume":12585,"amount":102149.6553,"timestamp":1766451559892},"volumeRatio":0.3847609026615311,"impliedVol":1.3528,"impliedVolPercentile":0.6225},"requestUrl":"/m/hq/s/KYTX/wiki","defaultTab":"wiki","newsList":[{"id":"2593431323","title":"Director Beth C. Seidenberg Acquires Common Shares of Kyverna Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2593431323","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593431323?lang=en_us&edition=fundamental","pubTime":"2025-12-23 00:44","pubTimestamp":1766421856,"startTime":"0","endTime":"0","summary":"Beth C. Seidenberg, Director, has reported the acquisition of common shares of Kyverna Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLc4TpDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"gpt_icon":0},{"id":"2593743131","title":"Westlake BioPartners Opportunity Fund I, L.P. Reports Acquisition of Kyverna Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593743131","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593743131?lang=en_us&edition=fundamental","pubTime":"2025-12-23 00:43","pubTimestamp":1766421798,"startTime":"0","endTime":"0","summary":"Westlake BioPartners Opportunity Fund I, L.P. has reported the acquisition of common shares of Kyverna Therapeutics Inc. , according to a recent SEC filing. The Form 4 was filed by more than one reporting person, including Westlake BioPartners Opportunity Fund I, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL9S5sH9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Westlake BioPartners Opportunity Fund I, L.P. Reports Acquisition of Kyverna Therapeutics Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2592409669","title":"Kyverna Therapeutics Chief Technology Officer Karen Marie Walker Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592409669","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592409669?lang=en_us&edition=fundamental","pubTime":"2025-12-18 09:30","pubTimestamp":1766021444,"startTime":"0","endTime":"0","summary":"Karen Marie Walker, Chief Technology Officer of Kyverna Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL57Kqwq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kyverna Therapeutics Chief Technology Officer Karen Marie Walker Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"gpt_icon":0},{"id":"2592911237","title":"Kyverna Therapeutics Down Over 29%, On Track for Largest Percent Decrease Since June 2024 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592911237?lang=en_us&edition=fundamental","pubTime":"2025-12-18 00:06","pubTimestamp":1765987560,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics, Inc.  is currently at $7.19, down $3.05 or 29.79%. --Would be lowest close since Dec. 3, 2025, when it closed at $7.18. --On pace for largest percent decrease since June 14, 2024, when it fell 34%. --Currently down two consecutive days; down 33.55% over this period. --Up 92.25% year-to-date; on pace for best year on record . --Down 76.11% from its all-time closing high of $30.10 on Feb. 9, 2024. --Up 89.71% from 52 weeks ago , when it closed at $3.79. --Down 33.55% from its 52-week closing high of $10.82 on Dec. 15, 2025. --Up 292.9% from its 52-week closing low of $1.83 on April 16, 2025. --Traded as low as $6.72; lowest intraday level since Dec. 3, 2025, when it hit $6.53. --Down 34.38% at today's intraday low; largest intraday percent decrease since June 14, 2024, when it fell as much as 39.06%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2592091186","title":"BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2592091186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592091186?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:40","pubTimestamp":1765986030,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocksEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN14O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNG","COUR","SCCO","FISI","HUT","ABM","XOM","CVX","HL","KYMR","MCK","WMB","NUE","COP","ALB","CYTK","APOG","VERU","FDX","FCF","TXRH","FCX","PANW","IMNM","CNX","FTNT","PSKY","SPOT","COR","HOOD","NFE","VSCO","WAT","JBL","DHR","TPL","XENE","VOR","NEO","NWBI","WSBC","AVTR","NEM","GIS","CVS","KYTX"],"gpt_icon":1},{"id":"2592915170","title":"Kyverna Therapeutics Inc - Underwriters Granted Option for 1,999,999 Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592915170","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592915170?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:24","pubTimestamp":1765981472,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA3BQPNT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2592791517","title":"Kyverna Therapeutics Inc - Prices Public Offering of 13,333,333 Shares of Common Stock at $7.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2592791517","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592791517?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:24","pubTimestamp":1765981472,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA3BQPNT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"gpt_icon":0},{"id":"2592478915","title":"Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2592478915","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592478915?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:24","pubTimestamp":1765981440,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., Dec.  17, 2025  (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell therapies for patie","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3207060/0/en/Kyverna-Therapeutics-Announces-Pricing-of-100-Million-Public-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU2357305700.SGD","LU0158827948.USD","LU0528227936.USD","LU2111349929.HKD","LU2271345857.HKD","LU0158827781.USD","BK4139","LU1548497426.USD","LU1074936037.SGD","LU1244550577.SGD","LU1989772840.SGD","LU2089283258.USD","LU0882574139.USD","LU1989772923.USD","LU1162221912.USD","LU1791710400.SGD","BK4516","LU1720051017.SGD","LU0098860793.USD","LU0971096721.USD","LU1732799900.SGD","LU2133065610.SGD","LU0267386448.USD","LU2028103732.USD","BK4127","LU0320765646.SGD","LU1732800096.USD","LU0795875169.SGD","BK4534","LU0557290698.USD","LU1244550494.USD","BK4588","LU2347655156.SGD","LU1720051108.HKD","LU0106831901.USD","IE00BZ1G4Q59.USD","LU1668664300.SGD","KYTX","LU0795875086.SGD","LU2023251221.USD","LU0912757837.SGD","LU1363072403.SGD","LU0006306889.USD","LU1791710582.SGD","LU0106261372.USD","LU1244550221.USD","BK4585"],"gpt_icon":0},{"id":"2592902059","title":"Investors Parse Jobs Data, Look Ahead to Inflation Report as US Futures Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592902059?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:12","pubTimestamp":1765977126,"startTime":"0","endTime":"0","summary":"US stock futures are tracking higher in Wednesday's premarket session as investors dissect Tuesday's employment reports, and look ahead to Thursday's inflation reading for November.The Dow Jones Indus","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2383074a52c258f664e165501a1e7f86","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZI","BK4211","BK7095","ISBC","KYTX","AZI.AU","BK4094","BK4595","HUT","PLCE","DBVT","BK4214","AMCI","BK4139","BK4023","BK4600"],"gpt_icon":1},{"id":"2591935933","title":"Kyverna Therapeutics Is Maintained at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2591935933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591935933?lang=en_us&edition=fundamental","pubTime":"2025-12-16 23:06","pubTimestamp":1765897560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 16, 2025 10:06 ET (15:06 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"gpt_icon":0},{"id":"2591984951","title":"Morgan Stanley Raises Price Target on Kyverna Therapeutics to $33 From $25, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2591984951","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591984951?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:51","pubTimestamp":1765889515,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (KYTX) has an average rating of buy and mean price target of $29.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KYTX"],"gpt_icon":0},{"id":"2591998562","title":"Kyverna Therapeutics Launches $100 Million Common Stock Offering; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2591998562","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591998562?lang=en_us&edition=fundamental","pubTime":"2025-12-16 18:52","pubTimestamp":1765882354,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics  said late Monday it launched a $100 million public offering of its common shares.The company plans to grant a 30-day overallotment option to the underwriters to acquire up to an additional $15 million of the shares.Kyverna shares were down 7.1% in recent premarket activity Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2591621210","title":"Press Release: Kyverna Therapeutics Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621210?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:01","pubTimestamp":1765832460,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., Dec. 15, 2025  -- Kyverna Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. Kyverna intends to grant the underwriters a 30-day option to purchase up to an additional $15,000,000 of shares of common stock offered in the public offering, at the public offering price, less underwriting discounts and commissions. All of the shares of common stock to be sold in the proposed offering will be sold by Kyverna. J.P. Morgan, Leerink Partners, Morgan Stanley and Wells Fargo Securities are acting as joint book-running managers for the offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU0557290698.USD","LU1989772923.USD","BK4534","LU0098860793.USD","LU0225283273.USD","LU1720051017.SGD","LU2111349929.HKD","LU0006306889.USD","LU0267386448.USD","LU0795875086.SGD","LU0912757837.SGD","LU1720051108.HKD","LU0234570918.USD","BK4127","BK4139","KYTX","LU0314104364.USD","LU2028103732.USD","LU2347655156.SGD","LU0106261372.USD","LU1791710400.SGD","BK4585","BK4588","BK4504","BK4516","LU1162221912.USD","IE00BZ1G4Q59.USD","LU2089284900.SGD","LU0882574139.USD","LU1732799900.SGD","LU0528227936.USD","LU1363072403.SGD","LU0158827781.USD","LU1244550221.USD","LU1244550494.USD","LU0320765646.SGD","BK4581","LU0106831901.USD","LU2271345857.HKD","LU1791710582.SGD","LU2133065610.SGD","LU0795875169.SGD","LU0971096721.USD","LU2357305700.SGD","LU1548497426.USD","LU0158827948.USD","LU1244550577.SGD","IE00BKVL7J92.USD","LU2023251221.USD"],"gpt_icon":0},{"id":"2591134626","title":"BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2591134626","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591134626?lang=en_us&edition=fundamental","pubTime":"2025-12-16 02:44","pubTimestamp":1765824246,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, NvidiaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL4N3XL10S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEM","KYTX","SCCO","SNVD.UK","TPL","NVDS.UK","CNX","SPOT","ZTS","DG","FMC","MOS","CRBG","LAZR","NVIW.SI","FAST","NVDX","NVDA","ENTG","VNDA","MIST","APD","AMAT","APA","FCX","CPB","JBL","NVDU","CVX","TXN","KLAC","LYB","NOW","HL","LRCX","ALB","XOM","CDE","NCLH","3NVD.UK","INGM","BMY","LNG","IMNM"],"gpt_icon":1},{"id":"2591628816","title":"BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628816?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:53","pubTimestamp":1765814010,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, ZillowEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235303.USD","FMC","LRCX","KLAC","LU0708995401.HKD","ALB","MIST","CRBG","LU0889565833.HKD","FAST","LU0048573561.USD","LYB","CDE","NEM","LU1992135399.USD","LU1989773731.SGD","NOW","DG","IMNM","ZTS","TSYW.SI","LU1223083913.SGD","LU0072463663.USD","FCX","LU2357125470.USD","CNX","KYTX","LU0648000940.SGD","HL","JBL","LU0654597011.USD","APD","VNDA","SCCO","LU0630314457.HKD","LU0053666078.USD","LU1861214812.USD","LU1720051108.HKD","LU0353189763.USD","LU1923622614.USD","AMAT","NCLH","LNG","LU1823568750.SGD","INGM"],"gpt_icon":1},{"id":"2591628531","title":"Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628531","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628531?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:45","pubTimestamp":1765813500,"startTime":"0","endTime":"0","summary":"U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Monday.Shares of Kyverna Therapeutics Inc  rose sharply during Monday's session after the company announced topline data from KYSA-8.The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2 trial of mivocabtagene autoleucel  in stiff person syndrome .Miv-cel is a fully human, autologous CD19-targeting CAR T-cell therapy with CD28 co-stimulation.Kyverna Therapeutics shares jumped 31% to $11.49 on Monday.Here are some other big stocks recording gains in today’s session.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/15/Section-Of-A-Financial-Newspaper-Titled-_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/15/Section-Of-A-Financial-Newspaper-Titled-_1.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/12/49395988/kyverna-therapeutics-immunome-almonty-industries-and-other-big-stocks-moving-higher-on-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/12/49395988/kyverna-therapeutics-immunome-almonty-industries-and-other-big-stocks-moving-higher-on-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4168","KYTX","BK4139","ALM"],"gpt_icon":0},{"id":"2591647573","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:54 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2591647573","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591647573?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:54","pubTimestamp":1765810475,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:54 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nAQN2LDO3G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2591902647","title":"Kyverna Stock Rockets After Cell Therapy Helps Patients Walk Again In Rare Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2591902647","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591902647?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:48","pubTimestamp":1765810080,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics, Inc.  stock rose Monday, with a session volume of 6.80 million compared to the average volume of 696.68 thousand as per data from Benzinga Pro.The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2 trial of mivocabtagene autoleucel  in stiff person syndrome .Miv-cel is a fully human, autologous CD19-targeting CAR T-cell therapy with CD28 co-stimulation.Also Read: Kyverna Sets Pace In Race For Autoimmune CAR-T Approval By 2026. Stiff Person Syndrome is a rare autoimmune neurological disorder causing progressive muscle stiffness, rigidity, and painful spasms, primarily in the torso and limbs, triggered by stimuli like noise or touch, leading to falls and disability as it worsens over time.It results from the immune system mistakenly attacking nerve cells controlling muscle movement.The single-arm registrational Phase 2 trial dosed 26 patients who had an inadequate response with non-approved treatment options, and received a single d","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/15/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/15/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49393558/kyverna-stock-rockets-after-cell-therapy-helps-patients-walk-again-in-rare-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49393558/kyverna-stock-rockets-after-cell-therapy-helps-patients-walk-again-in-rare-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU2065731478.USD","BK4139","BK4006","CRS","KYTX","LU0963586101.USD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B7SZL793.SGD","BK4187","IE00B66KJ199.SGD","BK4585","BK4588","DSI"],"gpt_icon":0},{"id":"2591964295","title":"Kyverna Therapeutics Shares Jump 39% After Co's Cell Therapy Meets Main Goal of Mid-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2591964295","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591964295?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:31","pubTimestamp":1765809092,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"gpt_icon":0},{"id":"2591774644","title":"BUZZ-U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow","url":"https://stock-news.laohu8.com/highlight/detail?id=2591774644","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591774644?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:18","pubTimestamp":1765808318,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNowEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL0MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBG","CVNA","LRCX","BK4550","FMC","LU0158827948.USD","NOW","APD","IMNM","NCLH","LU1989763005.USD","FCX","ZTS","MIST","LU2290526834.HKD","DG","AU","AMAT","NEM","NVMI","CDE","HL","IE0009356076.USD","IE00BJJMRY28.SGD","LU0011850046.USD","LU0640476718.USD","LU1551013342.USD","LU2360106780.USD","LU2931357623.SGD","LU0265550946.USD","LYB","MU","IE00BZ9MQY76.HKD","KLAC","BK4551","LU1778281490.HKD","IE0034235303.USD","IE00B7SZLL34.SGD","LU2237443382.USD","KYTX","LU1153585028.USD","LU2125909916.SGD","SCCO","BK4564","LU0256863811.USD","FAST","LU1223082196.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://kyvernatx.com","stockEarnings":[{"period":"1week","weight":-0.2486},{"period":"1month","weight":0.1467},{"period":"3month","weight":0.2884},{"period":"6month","weight":1.6482},{"period":"1year","weight":1.0325},{"period":"ytd","weight":1.1738}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Kyverna Therapeutics","nameEN":"Kyverna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kyverna Therapeutics(KYTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kyverna Therapeutics(KYTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kyverna Therapeutics,KYTX,Kyverna Therapeutics股票,Kyverna Therapeutics股票老虎,Kyverna Therapeutics股票老虎国际,Kyverna Therapeutics行情,Kyverna Therapeutics股票行情,Kyverna Therapeutics股价,Kyverna Therapeutics股市,Kyverna Therapeutics股票价格,Kyverna Therapeutics股票交易,Kyverna Therapeutics股票购买,Kyverna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kyverna Therapeutics(KYTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kyverna Therapeutics(KYTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction